Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

An European Myeloma Network recommendation on tools for diagnosis and monitoring of multiple myeloma: what to use and when.

Caers J, Garderet L, Kortüm KM, O'Dwyer ME, van de Donk NWCJ, Binder M, Dold SM, Gay F, Corre J, Beguin Y, Ludwig H, Larocca A, Driessen C, Dimopoulos MA, Boccadoro M, Gramatzki M, Zweegman S, Einsele H, Cavo M, Goldschmidt H, Sonneveld P, Delforge M, Auner HW, Terpos E, Engelhardt M.

Haematologica. 2018 Aug 31. pii: haematol.2018.189159. doi: 10.3324/haematol.2018.189159. [Epub ahead of print]

2.

GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study.

Schmidts A, Grünewald J, Kleber M, Terpos E, Ihorst G, Reinhardt H, Walz G, Wäsch R, Engelhardt M, Zschiedrich S.

Clin Exp Nephrol. 2018 Aug 20. doi: 10.1007/s10157-018-1626-7. [Epub ahead of print]

PMID:
30128942
3.

IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.

Plaumann J, Engelhardt M, Awwad MHS, Echchannaoui H, Amman E, Raab MS, Hillengass J, Halama N, Neuber B, Müller-Tidow C, Goldschmidt H, Hundemer M.

Cancer Immunol Immunother. 2018 Aug 20. doi: 10.1007/s00262-018-2230-0. [Epub ahead of print]

PMID:
30128739
4.

Fast prenatal development of the NPY neuron system in the neocortex of the European wild boar, Sus scrofa.

Ernst L, Darschnik S, Roos J, González-Gómez M, Beemelmans C, Beemelmans C, Engelhardt M, Meyer G, Wahle P.

Brain Struct Funct. 2018 Aug 9. doi: 10.1007/s00429-018-1725-y. [Epub ahead of print]

PMID:
30094604
5.

Carfilzomib.

Engelhardt M, Szymaniak-Vits M, Ajayi S, Dold SM, Müller SJ, Scheubeck S, Wäsch R.

Recent Results Cancer Res. 2018;212:265-283. doi: 10.1007/978-3-319-91439-8_13.

PMID:
30069635
6.

Pomalidomide.

Engelhardt M, Ajayi S, Reinhardt H, Müller SJ, Dold SM, Wäsch R.

Recent Results Cancer Res. 2018;212:169-185. doi: 10.1007/978-3-319-91439-8_8.

PMID:
30069630
7.

Ruxolitinib.

Ajayi S, Becker H, Reinhardt H, Engelhardt M, Zeiser R, von Bubnoff N, Wäsch R.

Recent Results Cancer Res. 2018;212:119-132. doi: 10.1007/978-3-319-91439-8_6.

PMID:
30069628
8.

Organization of the German Army Medical Service 1914-1918 and the role of academic surgeons.

Zischek C, Grunwald E, Engelhardt M.

Can J Surg. 2018 Aug;61(4):223-225.

9.

Detection of circulating tumour cell clusters in human glioblastoma.

Krol I, Castro-Giner F, Maurer M, Gkountela S, Szczerba BM, Scherrer R, Coleman N, Carreira S, Bachmann F, Anderson S, Engelhardt M, Lane H, Evans TRJ, Plummer R, Kristeleit R, Lopez J, Aceto N.

Br J Cancer. 2018 Aug;119(4):487-491. doi: 10.1038/s41416-018-0186-7. Epub 2018 Aug 1.

PMID:
30065256
10.

Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA).

Bringhen S, Milan A, Ferri C, Wäsch R, Gay F, Larocca A, Salvini M, Terpos E, Goldschmidt H, Cavo M, Petrucci MT, Ludwig H, Auner HW, Caers J, Gramatzki M, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M; European Hematology Association, the European Myeloma Network and the Italian Society of Arterial Hypertension.

Haematologica. 2018 Sep;103(9):1422-1432. doi: 10.3324/haematol.2018.191288. Epub 2018 Jul 26. Review.

11.

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.

Gavriatopoulou M, Musto P, Caers J, Merlini G, Kastritis E, van de Donk N, Gay F, Hegenbart U, Hajek R, Zweegman S, Bruno B, Straka C, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M, Terpos E.

Leukemia. 2018 Sep;32(9):1883-1898. doi: 10.1038/s41375-018-0209-7. Epub 2018 Jul 23. Review.

PMID:
30038381
12.

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.

Maertens J, Selleslag D, Heinz WJ, Saulay M, Rahav G, Giladi M, Aoun M, Kovanda L, Kaufhold A, Engelhardt M, Cornely OA, Herbrecht R, Ullmann AJ.

Mycoses. 2018 Jul 23. doi: 10.1111/myc.12831. [Epub ahead of print]

PMID:
30035825
13.

Impact of Atrial Fibrillation on Postoperative Adverse Outcomes of Surgical Patients With Knee Endoprosthetic Surgery.

Keller K, Hobohm L, Engelhardt M.

J Arthroplasty. 2018 Jun 26. pii: S0883-5403(18)30592-8. doi: 10.1016/j.arth.2018.06.022. [Epub ahead of print]

PMID:
30007790
14.

[Control of severe bleeding].

Engelhardt M.

Unfallchirurg. 2018 Jul;121(7):514-515. doi: 10.1007/s00113-018-0509-4. German. No abstract available.

PMID:
29992477
15.

NMDA Receptor-Mediated Motor Cortex Plasticity After 20 Hz Transcranial Alternating Current Stimulation.

Wischnewski M, Engelhardt M, Salehinejad MA, Schutter DJLG, Kuo MF, Nitsche MA.

Cereb Cortex. 2018 Jul 10. doi: 10.1093/cercor/bhy160. [Epub ahead of print]

PMID:
29992259
16.

[Resuscitative endovascular balloon occlusion of the aorta : Bridge to surgery].

Elias K, Engelhardt M.

Unfallchirurg. 2018 Jul;121(7):537-543. doi: 10.1007/s00113-018-0503-x. Review. German.

PMID:
29947830
17.

Nonoperative treatment of muscle injuries - recommendations from the GOTS expert meeting.

Hotfiel T, Seil R, Bily W, Bloch W, Gokeler A, Krifter RM, Mayer F, Ueblacker P, Weisskopf L, Engelhardt M.

J Exp Orthop. 2018 Jun 22;5(1):24. doi: 10.1186/s40634-018-0139-3. Review.

18.

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN).

Larocca A, Dold SM, Zweegman S, Terpos E, Wäsch R, D'Agostino M, Scheubeck S, Goldschmidt H, Gay F, Cavo M, Ludwig H, Straka C, Bringhen S, Auner HW, Caers J, Gramatzki M, Offidani M, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M.

Leukemia. 2018 Apr 25. doi: 10.1038/s41375-018-0142-9. [Epub ahead of print] Review.

PMID:
29880892
19.

Prediction of Safety Margin and Optimization of Dosing Protocol for a Novel Antibiotic using Quantitative Systems Pharmacology Modeling.

Woodhead JL, Paech F, Maurer M, Engelhardt M, Schmitt-Hoffmann AH, Spickermann J, Messner S, Wind M, Witschi AT, Krähenbühl S, Siler SQ, Watkins PB, Howell BA.

Clin Transl Sci. 2018 Sep;11(5):498-505. doi: 10.1111/cts.12560. Epub 2018 Jun 7.

20.

[Infusion of Daratumumab in Combination Therapies - Practical Information for The Outpatient Area].

Scheid C, Munder M, Salwender H, Engelhardt M.

Dtsch Med Wochenschr. 2018 Aug;143(16):1201-1206. doi: 10.1055/a-0595-5397. Epub 2018 Jun 6. German.

PMID:
29874684
21.

Pharmacokinetics and Target Attainment of Ceftobiprole in Asian and Non-Asian Subjects.

Muller AE, Punt N, Engelhardt M, Schmitt-Hoffmann AH, Mouton JW.

Clin Pharmacol Drug Dev. 2018 Sep;7(7):781-787. doi: 10.1002/cpdd.465. Epub 2018 May 16.

PMID:
29768717
22.

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Bladé J, Sonneveld P.

Leukemia. 2018 May 2. doi: 10.1038/s41375-018-0040-1. [Epub ahead of print] Review.

23.

Differential inputs to striatal cholinergic and parvalbumin interneurons imply functional distinctions.

Klug JR, Engelhardt MD, Cadman CN, Li H, Smith JB, Ayala S, Williams EW, Hoffman H, Jin X.

Elife. 2018 May 1;7. pii: e35657. doi: 10.7554/eLife.35657.

24.

Osteoprotective medication in the era of novel agents: a European perspective on values, risks and future solutions.

Engelhardt M, Herget GW, Graziani G, Ihorst G, Reinhardt H, Ajayi S, Knop S, Wasch R.

Haematologica. 2018 May;103(5):755-758. doi: 10.3324/haematol.2018.188516. No abstract available.

25.

NFATc1 Promotes Antitumoral Effector Functions and Memory CD8+ T-cell Differentiation during Non-Small Cell Lung Cancer Development.

Heim L, Friedrich J, Engelhardt M, Trufa DI, Geppert CI, Rieker RJ, Sirbu H, Finotto S.

Cancer Res. 2018 Jul 1;78(13):3619-3633. doi: 10.1158/0008-5472.CAN-17-3297. Epub 2018 Apr 24.

PMID:
29691251
26.

Cellular Plasticity in the Adult Murine Piriform Cortex: Continuous Maturation of Dormant Precursors Into Excitatory Neurons.

Rotheneichner P, Belles M, Benedetti B, König R, Dannehl D, Kreutzer C, Zaunmair P, Engelhardt M, Aigner L, Nacher J, Couillard-Despres S.

Cereb Cortex. 2018 Jul 1;28(7):2610-2621. doi: 10.1093/cercor/bhy087.

27.

Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma).

Waldschmidt JM, Keller A, Ihorst G, Grishina O, Müller S, Wider D, Frey AV, King K, Simon R, May A, Tassone P, Duyster J, Jung M, Raje N, Wäsch R, Engelhardt M.

Haematologica. 2018 Apr 19. pii: haematol.2018.189969. doi: 10.3324/haematol.2018.189969. [Epub ahead of print]

28.

Effect of changing postoperative pain management on bleeding rates in tonsillectomy patients.

Fonseca ACG, Engelhardt MI, Huang ZJ, Jiang ZY, Yuksel S, Roy S.

Am J Otolaryngol. 2018 Jul - Aug;39(4):445-447. doi: 10.1016/j.amjoto.2018.03.028. Epub 2018 Apr 5. Review.

PMID:
29655490
29.

Nonsurgical Clinical Management of Periapical Lesions Using Calcium Hydroxide-Iodoform-Silicon-Oil Paste.

Al Khasawnah Q, Hassan F, Malhan D, Engelhardt M, Daghma DES, Obidat D, Lips KS, El Khassawna T, Heiss C.

Biomed Res Int. 2018 Feb 12;2018:8198795. doi: 10.1155/2018/8198795. eCollection 2018.

30.

[Vascular surgical training concept for military surgeons in Germany].

Engelhardt M, Elias K, Friemert B, Klemm K, Willy C.

Unfallchirurg. 2018 Jul;121(7):544-549. doi: 10.1007/s00113-018-0485-8. Review. German.

PMID:
29594359
31.

Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae.

Marks R, Engelhardt M, Hager S, Füllgraf H, Südkamp NP, Herget GW.

Ann Hematol. 2018 Aug;97(8):1497-1500. doi: 10.1007/s00277-018-3308-7. Epub 2018 Mar 25. No abstract available.

PMID:
29574568
32.

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.

Perfect JR, Cornely OA, Heep M, Ostrosky-Zeichner L, Mullane KM, Maher R, Croos-Dabrera R, Lademacher C, Engelhardt M, Chen C, Marty FM.

Mycoses. 2018 Jul;61(7):420-429. doi: 10.1111/myc.12769. Epub 2018 Apr 19. Review.

PMID:
29570857
33.

Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials.

Gengenbach L, Reinhardt H, Ihorst G, Ajayi S, Dold SM, Köhler M, Einsele H, Duyster J, Wäsch R, Engelhardt M.

Leuk Lymphoma. 2018 Mar 23:1-8. doi: 10.1080/10428194.2018.1448084. [Epub ahead of print] No abstract available.

PMID:
29569975
34.

Closed-incision negative pressure therapy to reduce groin wound infections in vascular surgery: a randomised controlled trial.

Engelhardt M, Rashad NA, Willy C, Müller C, Bauer C, Debus S, Beck T.

Int Wound J. 2018 Jun;15(3):327-332. doi: 10.1111/iwj.12848. Epub 2018 Mar 12.

PMID:
29527812
35.

Current developments in immunotherapy in the treatment of multiple myeloma.

Köhler M, Greil C, Hudecek M, Lonial S, Raje N, Wäsch R, Engelhardt M.

Cancer. 2018 May 15;124(10):2075-2085. doi: 10.1002/cncr.31243. Epub 2018 Feb 6. Review.

PMID:
29409124
36.

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

Caers J, Paiva B, Zamagni E, Leleu X, Bladé J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosiñol L.

J Hematol Oncol. 2018 Jan 16;11(1):10. doi: 10.1186/s13045-017-0549-1. Review.

37.

Interneuron synaptopathy in developing rat cortex induced by the pro-inflammatory cytokine LIF.

Engelhardt M, Hamad MIK, Jack A, Ahmed K, König J, Rennau LM, Jamann N, Räk A, Schönfelder S, Riedel C, Wirth MJ, Patz S, Wahle P.

Exp Neurol. 2018 Apr;302:169-180. doi: 10.1016/j.expneurol.2017.12.011. Epub 2018 Jan 2. No abstract available.

PMID:
29305051
38.

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.

Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Sonneveld P.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.353. [Epub ahead of print] Review.

39.

Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells.

Neuber B, Dai J, Waraich WA, Awwad MHS, Engelhardt M, Schmitt M, Medenhoff S, Witzens-Harig M, Ho AD, Goldschmidt H, Hundemer M.

Oncotarget. 2017 Oct 5;8(58):98200-98214. doi: 10.18632/oncotarget.21516. eCollection 2017 Nov 17.

40.

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.

Gay F, Engelhardt M, Terpos E, Wäsch R, Giaccone L, Auner HW, Caers J, Gramatzki M, van de Donk N, Oliva S, Zamagni E, Garderet L, Straka C, Hajek R, Ludwig H, Einsele H, Dimopoulos M, Boccadoro M, Kröger N, Cavo M, Goldschmidt H, Bruno B, Sonneveld P.

Haematologica. 2018 Feb;103(2):197-211. doi: 10.3324/haematol.2017.174573. Epub 2017 Dec 7. Review.

41.

Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.

Kontoyiannis DP, Selleslag D, Mullane K, Cornely OA, Hope W, Lortholary O, Croos-Dabrera R, Lademacher C, Engelhardt M, Patterson TF.

J Antimicrob Chemother. 2017 Nov 29. doi: 10.1093/jac/dkx423. [Epub ahead of print]

PMID:
29194488
42.

Heterogeneity of the Axon Initial Segment in Interneurons and Pyramidal Cells of Rodent Visual Cortex.

Höfflin F, Jack A, Riedel C, Mack-Bucher J, Roos J, Corcelli C, Schultz C, Wahle P, Engelhardt M.

Front Cell Neurosci. 2017 Nov 6;11:332. doi: 10.3389/fncel.2017.00332. eCollection 2017.

43.

Intracranial Ischemic Infarct Due to Blunt Force Trauma in a High School Football Player.

Esianor BI, Haider AS, Engelhardt MI, Osumah T, Vayalumkal S, Thakur R, Leonard D, Haithcock J, Layton KF.

Cureus. 2017 Sep 7;9(9):e1659. doi: 10.7759/cureus.1659.

44.

Mycotic Pseudoaneurysm Associated with Skull Base Osteomyelitis Treated with Endovascular Embolization.

Haider AS, Esianor BI, Shail MS, Engelhardt MI, Kafai Golahmadi A, Khan R, Khan U, Vayalumkal S, Thakur R, Layton KF.

Cureus. 2017 Aug 28;9(8):e1622. doi: 10.7759/cureus.1622.

45.

Stem cell mobilization in poor mobilizers with multiple myeloma or lymphoma before and after introduction of plerixafor: a single-center comparative analysis using a cost-efficient single fixed-dose schedule.

Greil C, Ihorst G, Kiote-Schmidt C, Hildenbeutel S, Kühbach K, Bosse R, Duyster J, Engelhardt M, Wäsch R.

Leuk Lymphoma. 2018 Jul;59(7):1722-1725. doi: 10.1080/10428194.2017.1393673. Epub 2017 Oct 30. No abstract available.

PMID:
29081261
46.

Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature.

Rassner MP, Seidl M, Salzer U, Rajkumar SV, Epting T, Wäsch R, Neumann-Haefelin E, Engelhardt M.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e1-e7. doi: 10.1016/j.clml.2017.09.019. Epub 2017 Oct 3. No abstract available.

PMID:
29066226
47.

Multiple Taf subunits of TFIID interact with Ino2 activation domains and contribute to expression of genes required for yeast phospholipid biosynthesis.

Hintze S, Engelhardt M, van Diepen L, Witt E, Schüller HJ.

Mol Microbiol. 2017 Dec;106(6):876-890. doi: 10.1111/mmi.13850. Epub 2017 Oct 17.

PMID:
28994223
48.

A New Clinically Relevant T-Score Standard to Interpret Bone Status in a Sheep Model.

Heiss C, Kern S, Malhan D, Böcker W, Engelhardt M, Daghma DES, Stoetzel S, Schmitt J, Ivo M, Kauschke V, Lips KS, Tushtev K, Rezwan K, El Khassawna T.

Med Sci Monit Basic Res. 2017 Oct 2;23:326-335.

49.

Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.

Einsele H, Engelhardt M, Tapprich C, Müller J, Liebisch P, Langer C, Kropff M, Mügge LO, Jung W, Wolf HH, Metzner B, Hart C, Gramatzki M, Hertenstein B, Pfreundschuh M, Rösler W, Fischer T, Maschmeyer G, Kanz L, Hess G, Jäger E, Bentz M, Dürk HA, Salwender H, Hebart H, Straka C, Knop S.

Br J Haematol. 2017 Nov;179(4):586-597. doi: 10.1111/bjh.14920. Epub 2017 Sep 29.

PMID:
28961309
50.

Structural Plasticity of Synaptopodin in the Axon Initial Segment during Visual Cortex Development.

Schlüter A, Del Turco D, Deller T, Gutzmann A, Schultz C, Engelhardt M.

Cereb Cortex. 2017 Sep 1;27(9):4662-4675. doi: 10.1093/cercor/bhx208.

PMID:
28922860

Supplemental Content

Loading ...
Support Center